Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Journal: Urologic oncology
Published: September 07, 2020
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
Journal: The Journal of urology
Published: July 20, 2017
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
Journal: Journal of the National Cancer Institute
Published: April 13, 2015
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.
Journal: Cancer
Published: December 22, 2014
Observation versus initial treatment for prostate cancer.
Journal: Annals of internal medicine
Published: October 16, 2013
Reply to clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease.
Journal: Cancer
Published: October 12, 2013
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
Journal: Annals of internal medicine
Published: June 20, 2013
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease.
Journal: Cancer
Published: February 01, 2013
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
Journal: BJU international
Published: August 30, 2012
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.
Journal: Cancer
Published: October 03, 2011
Last Updated: 09/26/2026